New final guidance from the FDA is intended to clarify whether activities that medical device companies perform on their products constitute remanufacturing rather than servicing — thereby triggering a range of compliance requirements under the Federal Food, Drug, and Cosmetic Act and the agency’s regulations. A remanufactured device is subject to the FDA’s establishment regi... Read More